Opus Point…investing in Innovation
We are committed to identifying and investing in innovations in life science and healthcare that will change the way diseases are diagnosed, the way patients are cared for and the way healthcare and medicine are delivered to patients.
We focus on investments in publicly-traded biotech and life sciences companies, through our hedge fund, Opus Point Healthcare Innovations Fund. Opus’s investment approach is unique and leverages the many years of collective experience of our founders to drive superior investment returns in a risk-mitigated, diverse, liquid investment approach. Opus invests across market caps and keeps an approximate equal weight of small, mid and large cap investments.
In addition to investing in publicly-traded companies, the principals have significant experience in starting, managing and financing biotechnology companies. On a highly selective and limited basis, the partners, will provide seed capital and otherwise assist entrepreneurs in launching their new companies and help pharmaceutical companies in spinning-out assets.